University of Pittsburgh
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Pittsburgh sits in the top decile of US sponsors by registered trial count (#22 of 15,742 sponsors by registered trial count).
University of Pittsburgh: 1,238 sponsored US clinical trials, 160 recruiting.
University of Pittsburgh sponsors 1,238 registered US clinical trials on ClinicalTrials.gov, 160 of them currently recruiting, and 917 completed. 84 of these trials are in Phase 3-4 (later-stage) and 160 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 17 trials.
Top-decile sponsor footprint
University of Pittsburgh ranks in the top decile of sponsors by registered trial count (#22 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
917 of 1,014 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,238 total, page 19 of 25
Brief Behavioral Treatment of Insomnia in Military Veterans: Phase 1
NCT00679406
Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 12.06.07(DMID Protocol #07-0036)
NCT00235690
Imaging Antidepressant vs. Cognitive Behavior Therapy Effects on Unipolar Depression
NCT00787501
Aprepitant for PONV Prophylaxis in Outpatient Plastic Surgery
NCT00659945
Evaluating the Effects of Omega-3 Fatty Acids on Heart Disease and Behavior
NCT00663871
Pilot Study Evaluating Characteristic Closure Patterns of the Normal Velopharyngeal Portal
NCT00773994
Melanoma Molecular Profiling Analysis
NCT00889980
Nitrofurantoin and Urinary Tract Infections (UTIs)
NCT00678041
T- BOOM Teens--Building Options and Opportunities for Moms
NCT00745537
Osteogenic Profiling of Tissue From Children With Craniosynostosis
NCT00773643
Identifying and Facilitating Ventricular Recovery on Mechanical Support
NCT00687856
Patient Satisfaction Study: Clean Intermittent Self-Catheterization Teaching
NCT00678444
Study of Aripiprazole to Reduce Medical Risks in Bipolar Disorder
NCT00665444
Improving Diabetes After Bariatric Surgery
NCT00676923
Effects of a Weight Reduction and Lifestyle Program in Older Adults
NCT00714506
Daptomycin Study - Collection of Pharmacokinetic Samples in Patients With Renal Failure
NCT00573898
Evaluating the Effectiveness of a Stepped-Care Approach to Long-Term Weight Loss (The Step-Up Study)
NCT00714168
Effect of Lumbrical Stretching on Carpal Tunnel Syndrome
NCT00803257
Protocolized Care for Early Septic Shock
NCT00510835
Self-dispersing Liquids as Aerosol Drug Carriers
NCT00628134
The Feasibility of Simplified Telephone Follow-up After Medical Abortion
NCT00619658
One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study
NCT00580788
Eustachian Tube Testing in a Pressure Chamber -- Validation Study
NCT00694486
Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms
NCT01640522
Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness
NCT00769353
Facilitating Caregiver Adaptation to Patient Institutionalization
NCT01194128
Effectiveness and Safety Study of TACE Plus Oral Sorafenib for Unresectable HCC
NCT00576056
Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding Study
NCT00464542
Physical Activity Following Surgery Induced Weight Loss
NCT00692367
The Effect of a Coordinated Inpatient Diabetes Education Program in the Outpatient Setting
NCT00657800
Zoledronic Acid for Osteoporosis in the Elderly
NCT00558012
Dietary Adherence Enhancement in Peritoneal Dialysis: BalanceWise-PD
NCT00447317
Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms
NCT00573521
Phase II Trial of Doxorubicin and Bortezomib in Patients With Incurable Adenoid Cystic Carcinoma of the Head and Neck
NCT00581360
Reconstruction of 12-Lead Electrogram From Intracardiac Signals From Defibrillators During or After Implantation
NCT00890461
Efficacy of Functional Electrical Stimulation (FES) in Persons Receiving Botulinum Neurotoxin for Upper Extremity Spasticity
NCT00462449
Physical Activity in Youth: Implications for Reversing Risk Factors for Type 2 Diabetes
NCT00739180
Absorptive Clearance in the Cystic Fibrosis Airway
NCT00541190
Epidemiology of Community - Associated Extended-spectrum Beta-lactamases (ESBL) Producing Escherichia Coli
NCT00573235
Tinidazole for Recurrent Bacterial Vaginosis: A Pilot Study
NCT00510614
Pilot Study of Adding Raltegravir (MK-0518) to Antiretroviral Therapy in Patients With Low Level Viremia
NCT00618371
Aerosol Cyclosporine in Chronic Obstructive Pulmonary Disease (COPD)
NCT00783107
Randomized Trial of Alternative Quadrivalent Human Papilloma Virus (HPV) Vaccination Schedules in a University Setting
NCT00572832
Strategies to Avoid Returning to Smoking
NCT00757068
Prolotherapy for the Treatment of Chronic Lateral Epicondylitis
NCT00674622
Cognitive Stimulation Program in AIDS
NCT00619567
Reducing Depressive Symptoms in Physically Ill Youth
NCT00534911
Pennsylvania Idiopathic Pulmonary Fibrosis Research Registry
NCT00540475
Risk Factors for Linezolid Resistance in Staphylococcus Aureus
NCT00519025
Pancreatic Enzymes to Restore Digestive Function in Malnourished Gastric Bypass Patients
NCT00510744
What is open in the University of Pittsburgh pipeline
160 recruiting of 1,238 indexed (13% open); 917 completed (74%).
Phase mix: 84 late (III/IV) vs 160 early (I/II) (early-phase heavy).
Top condition: Depression (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Pittsburgh: open-pipeline peers nationwide
Peers matched on 1,238 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
University of Pittsburgh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,238 trials (± recruiting share)
- Northwestern University · 1,209 trials · 15% recruiting
- Emory University · 1,208 trials · 17% recruiting
- University of Colorado, Denver · 1,283 trials · 21% recruiting
- AstraZeneca · 1,285 trials · 12% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Intermountain Health Care · 13% recruiting · 85 trials
- McMaster University · 13% recruiting · 31 trials
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · 13% recruiting · 93 trials
- Temple University · 13% recruiting · 163 trials
Related
What to do with this University of Pittsburgh page
1,238 registered trials is a research-attention snapshot, not an endorsement of University of Pittsburgh or any single study.
- 160 of University of Pittsburgh's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of Pittsburgh studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Pittsburgh pipeline card: 1,238 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.